RECAP ESMO 2026 — 117 trials, 1,732 results slides and physician reactions, all in one place See ESMO 2026 results →
Urvi Shah profile photo
KOL Pulse Profile · 2026

Urvi Shah

Associate Attending Physician, Myeloma Service · Memorial Sloan Kettering Cancer Center · Institution profile ↗

Oncologist and researcher on Myeloma service @mskcancercenter Interested in nutrition 🌱 for cancer and immune therapies. Cancer survivor. Views are my own

Urvi Shah (@urvishahmd) ranks #19 among US multiple myeloma KOLs on X in 2026, by engagement from fellow physicians. 5 physicians shared, quoted or replied to their posts this year. Most-discussed trials in 2026: NUTRIVENTION. CMS Open Payments lists $2,567 in 2025 general payments.

Urvi Shah, #19 multiple myeloma KOL in the USA, KOL Pulse 2026 rankings
Urvi Shah, #19 multiple myeloma KOL in the USA, KOL Pulse 2026 rankings

At a Glance

This Month

What Urvi Shah has posted in the last 30 days. Updated November 11, 2026.

No trial posts in the last 30 days.

2026 Rankings

ListUS rankGlobal rankPeer Engagement ScorePhysicians engagedPhysician engagements
Multiple Myeloma#19—44/10057Full ranking

What Colleagues Are Saying About Urvi Shah

2026 posts by fellow physicians that mention @urvishahmd, quoted word for word.

#ASHKudos to @UrviShahMD for getting this to finish line in time for #ASH25! High fiber plant-based diets in myeloma precursors: Something our patients ask about, and something we have data for now! QOL, inflam benefits - and in some cases, alteration of #MMsm trajectory! https://t.co/wMuwDmyWR0
Rahul Banerjee, MD, FACP (@RahulBanerjeeMD) · · View on X ↗

Trials Urvi Shah Discussed since ASH 2025

TrialPostsRank among physicians postingLatest
NUTRIVENTION1—Dec 4, 2025

Urvi Shah on NUTRIVENTION

Consumption of a western diet and high BMI are risk factors for progression from pre-malignant phenotypes to cancer MM. In the NUTRIVENTION trial (NCT04920084), we administered a high-fiber, plant-based diet to 23 pts with MM precursor states and elevated BMI. #mmsm #ASH25
114 impressions · View on X ↗

Urvi Shah’s Most-Engaged Posts since ASH 2025

Their own 2026 posts that fellow physicians reposted most, quoted word for word.

This is a great strategy for resource limited countries reducing cost significantly. Are infection risks lower too? Look forward to the data #ASH25 @GomezDLeonMD @dgomezalmaguer @rennquevedo https://t.co/kAHq7tDmer
1,605 impressions · View on X ↗
I would like to take this opportunity to thank mentors, collaborators and study participants who believed in the importance of this work. @Matteo_MSB @DrMvandenBrink @LesokhinMD @szusmani @Neil_Iyengar @DrOlaLandgren @Leif_Bergsagel @GiraltSergio Anita D'Souza #ASH25 #mmsm
620 impressions · View on X ↗
We show for the first time that a high-fiber diet is a low-risk intervention that may delay progression to myeloma. This project is truly team science and an amazing collaborative effort that spans multiple institutions, 3 countries and 7 years. #ASH25 #mmsm
4,717 impressions · View on X ↗
The intervention was feasible, improved quality of life and modifiable factors: metabolic (BMI, insulin resistance), microbiome (diversity, composition), and immune (inflammation, monocyte subsets). Disease-progression trajectory improved (n=2) or was stable. #mmsm #ASH25
104 impressions · View on X ↗

Industry Payments

CMS Open Payments · 2025 general payments
$2,567 across 5 payments
View the CMS record ↗
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • ✓Enhanced KOL profiles
  • ✓Pharma influence & potential advisory-board patterns
  • ✓2025 Open Payments financial analysis
  • ✓Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.

FAQ

How does Urvi Shah rank among oncology KOLs in 2026?

Urvi Shah ranks #19 among US multiple myeloma KOLs on X in 2026, based on engagement from fellow physicians (KOL Pulse rankings, updated November 11, 2026). Peer Engagement Score: 44/100 in multiple myeloma, where the top-ranked physician worldwide in each tumor type scores 100.

Which clinical trials does Urvi Shah discuss most?

In 2026, Urvi Shah posted most often about NUTRIVENTION. Each post is quoted word for word on this page with a link to the original.

Does Urvi Shah receive industry payments?

CMS Open Payments lists $2,567 in 2025 general payments. Source: CMS Open Payments, program year 2025.

See something wrong? Report an issue with this profile.

KOL Pulse analysis · Reviewed by Brian Shields, Founder, KOL Pulse · Updated